Pfizer
High Court rules against Pfizer in Lyrica patent case
September 10, 2015Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin
The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …
Pfizer completes $15 billion Hospira acquisition
September 4, 2015Biosimilar Drugs, Hospira, Pfizer, mergers and acquisitions
Pfizer has completed its acquisition of Illinois-based injectable drugs and infusion device specialist Hospira for around $15 billion.The deal, first announced …
Alvogen buys four-drug portfolio from Pfizer
August 27, 2015Sales and Marketing Alvogen, Pfizer
Alvogen has entered into a agreement with Pfizer to purchase a portfolio of four pharmaceutical products for the US market, …
FDA hits Mylan’s Indian plants with warning letter
August 20, 2015Manufacturing and Production Contamination, FDA, Mylan, Pfizer, manufacturing, production
The FDA has served Mylan with a warning letter citing contamination at three of its manufacturing facilities in India. Inspections …
Pfizer offers to pay for UK Lyrica switches
August 13, 2015Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin
Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …
Pfizer and Flynn rapped for overcharging on anti-epilepsy drug
August 6, 2015Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing
Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …
Novartis and Pfizer to close factories in India
July 21, 2015Manufacturing and Production India, Novartis, Pfizer, Sandoz, manufacturing
Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …
Pfizer partners with NIHR to boosts UK R&D
July 1, 2015Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies
Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …
Pfizer acquires meningitis vaccines from GSK
June 23, 2015Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, Pfizer, meningitis
Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …
GSK ploughs $95m into research institute
June 17, 2015Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover
GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …
Pfizer expands in China with $95m consumer products plant
June 16, 2015Manufacturing and Production, Sales and Marketing Asia, China, Pfizer, brett wells, production
Pfizer says it has broken ground with a $95 million production facility in Suzhou in China to expand its production …
Pfizer breast cancer drug delivers
June 1, 2015Sales and Marketing ASCO, AZ, Faslodex, Pfizer, breast cancer, brett wells
A Phase III study on Pfizer’s treatment Ibrance in combination with hormone therapy has revealed the drug more than doubled …
Pfizer gets first approval for rare lung disease
May 29, 2015Sales and Marketing FDA, Pfizer, Rapamune, lung disease
Pfizer’s Rapamune will become the first drug available to treat the very rare lung disease lymphangioleiomyomatosis (LAM) after receiving approval …
Analysts predict Pfizer to swallow GSK
May 21, 2015Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger
GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …
Pfizer board member stepping down
May 21, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Marc Tessier-Lavigne, Pfizer
Dr Marc Tessier-Lavigne is leaving Pfizer’s board of directors to work on the launch of Denali, a new biotech company …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
